Full Text View
Tabular View
No Study Results Posted
Related Studies
Antiproteinuric Effect of Valsartan and Lisinopril
This study has been completed.
Study NCT00171574   Information provided by Novartis
First Received: September 12, 2005   Last Updated: February 9, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hypertension
Diabetic Nephropathy
Additional conditions recognized in this trial
Diabetic Nephropathies
Kidney Diseases
More general conditions related to this trial
Cardiovascular Diseases
Diabetes Complications
Diabetes Mellitus
Endocrine System Diseases
Urologic Diseases
Vascular Diseases
Interventions listed in this trial
Valsartan
Valsartan plus HCTZ
Lisinopril
More general drug interventions related to this trial
Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents
Cardiotonic Agents
Cardiovascular Agents
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protease Inhibitors
Protective Agents
Therapeutic Uses
Sponsors listed in this trial
Novartis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services